PLIANT THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT December 19, 2019Investors’ Rights Agreement • March 16th, 2020 • Pliant Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 16th, 2020 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 19th day of December, 2019, by and among PLIANT THERAPEUTICS, INC., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, (together with any subsequent investors who become parties hereto as “Investors” in accordance with Section 6.9 hereto, collectively, the “Investors”).